Most recently in June, the House Oversight Committee released an in-depth report, detailing a dramatic drop in the production of generic injectable drugs.
FORBES: FDA SpyGate -- New Revelations Challenge The New York Times Investigation of Agency "Enemies List," Raise More Questions About the 'Government's Most Dysfunctional Agency'